FDA Announces Guidance for Sponsors of Certain Oncology Drugs for Companion Animals Today, the FDA issued the final version of Guidance for Industry #237 - Oncology Drugs for Companion Animals. The agency did not receive comments on the draft guidance; therefore, the final guidance contains only minor editorial changes. |